country,Region,lat,long,displayName,layerName,layerTitle,year,value,study.Id,site.number,site,study.start,study.end,marker.type,tested,present,Mixed.present,author,publication.year,publication.URL,title,notes,pubmed.Id,drug,marker.group,percentage,included.or.excluded,PR,Prev_DR
Afghanistan,Asia,34.43,70.45,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.0024233912117779255,21699697,2,Jalalabad,2002,2003,pfmdr1 86Y,151,33,33,Howard N,2011,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3132200&tool=pmcentrez&rendertype=abstract,NA,21699697,Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan.,Amodiaquine,pfmdr1 86Y,22,NA,0.24233912117779255,21.85430463576159
Angola,Southern Africa,-7.61,15.05,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.2623843848705292,19708897,0,Uige Provincial Hospital,2004,2004,pfmdr1 86Y,66,24,45,Menegon M,2009,http://www.ncbi.nlm.nih.gov/pubmed/19708897,NA,19708897,"Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola.",Amodiaquine,pfmdr1 86Y,68,NA,26.238438487052917,36.36363636363637
Angola,Southern Africa,-8.84,13.23,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.06970688700675964,19014684,0,Luanda,2005,2005,pfmdr1 86Y,199,122,142,Figueiredo P,2008,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2613152&tool=pmcentrez&rendertype=abstract,NA,19014684,"Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.",Amodiaquine,pfmdr1 86Y,71,NA,6.970688700675964,61.30653266331658
Bangladesh,Asia,23.24,92.07,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.04203068092465401,15189458,0,"Dighinala upazilla, Baghaichara, Pujgang, Panchari upazilla",2002,2002,pfmdr1 86Y,173,121,121,van den Broek IVF,2004,http://www.ncbi.nlm.nih.gov/pubmed/?term=15189458,Clinical Q+SP data available. Mixed infection,15189458,Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts,Amodiaquine,pfmdr1 86Y,70,NA,4.203068092465401,69.94219653179191
Brazil,South America,-3.77,-49.68,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.0002954551891889423,18304266,0,Tucurui,2005,2005,pfmdr1 86Y,56,0,0,Ferreira ID,2008,http://www.ncbi.nlm.nih.gov/pubmed/18304266,In vitro ARS ARM data available.,18304266,Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6.,Amodiaquine,pfmdr1 86Y,0,NA,0.02954551891889423,0
Burkina Faso,West Africa,11.18,-4.29,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2000,0.7272407412528992,14636690,0,Bobo Dioulasso,1998,2000,pfmdr1 86Y,94,23,34,Tinto H,2003,http://www.ncbi.nlm.nih.gov/pubmed/?term=14636690,Clinical CQ data and in vitro data available.,14636690,Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso,Amodiaquine,pfmdr1 86Y,36,NA,72.72407412528992,24.46808510638298
Burkina Faso,West Africa,12.58,-1.3,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.7829916477203369,17538894,0,"Ziniaré, Boussé",2002,2002,pfmdr1 86Y,999,445,445,Diallo DA,2007,http://www.ncbi.nlm.nih.gov/pubmed/17538894,Clinical CQ data available. In the publicatio,17538894,Children in Burkina Faso who are protected by insecticide-treated materials are able to clear drug-resistant parasites better than unprotected children.,Amodiaquine,pfmdr1 86Y,45,NA,78.29916477203369,44.54454454454454
Burkina Faso,West Africa,11.18,-4.29,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.6861259937286377,16837725,0,Bobo-Dioulasso,2003,2003,pfmdr1 86Y,110,48,48,Dokomajilar C,2006,http://www.16837725.nlm.nih.gov/pubmed/16837725,Clinical AQ data and post-treatment genotypes,16837725,Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.,Amodiaquine,pfmdr1 86Y,44,I,68.61259937286377,43.63636363636363
Burkina Faso,West Africa,12.73,-3.87,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.45815056562423706,20060374,0,Nouna,2005,2005,pfmdr1 86Y,111,18,35,Danquah I,2010,http://www.ncbi.nlm.nih.gov/pubmed/20060374,"Clinical data AQ, post-treatment genotypes",20060374,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,Amodiaquine,pfmdr1 86Y,32,NA,45.815056562423706,16.216216216216218
Burkina Faso,West Africa,12.35,-1.52,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.19572493433952332,18304270,0,NA,2005,2005,pfmdr1 86Y,195,58,58,Tinto H,2008,http://www.ncbi.nlm.nih.gov/pubmed/18304270,Clinical AQ data available.,18304270,Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso.,Amodiaquine,pfmdr1 86Y,30,NA,19.57249343395233,29.743589743589745
Burkina Faso,West Africa,12.35,-1.52,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.19572493433952332,25403659,1,NA,2005,2005,pfmdr1 86Y,272,49,102,"Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Van Overmeir C, Rosanas-Urgell A, Van Geertruyden JP, D'Alessandro U, Erhart A",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=25403659,NA,25403659,In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.,Amodiaquine,pfmdr1 86Y,38,NA,19.57249343395233,18.014705882352946
Cambodia,SEA,12.91,102.67,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.12281662225723267,17426163,0,Pailin,2004,2004,pfmdr1 86Y,75,0,0,Alker AP,2007,http://www.ncbi.nlm.nih.gov/pubmed/17426163,Clinical ARM+MQ data and post-treatment genot,17426163,Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.,Amodiaquine,pfmdr1 86Y,0,NA,12.281662225723268,0
Cambodia,SEA,12.33,103.48,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.04888862371444702,19138391,0,"Veal Veng, Sampovloun",2002,2004,pfmdr1 86Y,138,0,0,Lim P,2009,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2627910&tool=pmcentrez&rendertype=abstract,"Clinical data ARM-MQ, ARM-LUM. In vitro data.",19138391,Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.,Amodiaquine,pfmdr1 86Y,0,NA,4.888862371444702,0
Cameroon,Central Africa,3.87,11.52,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2000,0.5101032257080078,12224572,0,Yaoundé,1997,2000,pfmdr1 86Y,64,56,57,Basco L,2002,http://www.ncbi.nlm.nih.gov/pubmed/12224572,In vitro data available.,12224572,Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives.,Amodiaquine,pfmdr1 86Y,89,NA,51.01032257080078,87.5
Cameroon,Central Africa,4.09,9.31,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.5985939502716064,631,1,Mutengene,2003,2005,pfmdr1 86Y,226,189,189,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,NA,29854394,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",Amodiaquine,pfmdr1 86Y,84,I,59.859395027160645,83.6283185840708
Central African Republic,Central Africa,4.37,18.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.7907419204711914,16474071,0,Bangui,2004,2004,pfmdr1 86Y,224,24,49,Menard D,2006,http://www.ncbi.nlm.nih.gov/pubmed/16474071,NA,16474071,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",Amodiaquine,pfmdr1 86Y,22,NA,79.07419204711914,10.714285714285714
Central African Republic,Central Africa,4.37,18.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.8523999452590942,740,1,NA,2002,2005,pfmdr1 86Y,139,72,72,"Amor A, Toro C, FernÃ¡ndez-MartÃ­nez A, Baquero M, Benito A, Berzosa P.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22462737,NA,22462737,Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.,Amodiaquine,pfmdr1 86Y,52,NA,85.23999452590942,51.798561151079134
China,Asia,20.02,110.35,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0,15827277,4,Hainan,2001,2001,pfmdr1 86Y,54,0,0,Wang X,2005,http://www.ncbi.nlm.nih.gov/pubmed/?term=15827277,In vitro data available.,15827277,Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan,Amodiaquine,pfmdr1 86Y,10,NA,0,0
Colombia,South America,4,-73.28,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.00032797406311146915,17713631,1,Baja Cauca,2002,2004,pfmdr1 86Y,68,0,0,Montoya P,2007,http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572007000200007&lng=en&nrm=iso&tl,Article in Spanish.,17713631,[Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].,Amodiaquine,pfmdr1 86Y,0,NA,0.03279740631114691,0
Colombia,South America,1.81,-78.76,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.07411354780197144,17713631,3,Tumaco,2002,2004,pfmdr1 86Y,89,0,0,Montoya P,2007,http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572007000200007&lng=en&nrm=iso&tl,Article in Spanish.,17713631,[Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].,Amodiaquine,pfmdr1 86Y,0,NA,7.4113547801971444,0
Colombia,South America,8.1,-76.73,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.007365812547504902,17713631,2,Turbo,2002,2004,pfmdr1 86Y,73,4,4,Montoya P,2007,http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572007000200007&lng=en&nrm=iso&tl,Article in Spanish.,17713631,[Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].,Amodiaquine,pfmdr1 86Y,5,NA,0.7365812547504902,5.47945205479452
Colombia,South America,8.1,-76.73,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.004814071115106344,18426617,0,"Turbo, Necocli, El Bagre, Zaragoza",2004,2005,pfmdr1 86Y,77,0,0,RESTREPO-PINEDA E,2008,http://www.ncbi.nlm.nih.gov/pubmed/18426617,In vitro data available.,18426617,"Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt.",Amodiaquine,pfmdr1 86Y,0,NA,0.4814071115106344,0
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.2652883529663086,806,2,NA,2001,2001,pfmdr1 86Y,102,98,98,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, González V, García L, Rodríguez-Galet A, Díaz-Regañón R, Galán R, Cerrada-Gálvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,NA,34906159,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20 years (1999 to 2019).,Amodiaquine,pfmdr1 86Y,96,NA,26.52883529663086,96.07843137254902
Equatorial Guinea,Central Africa,1.75,10.17,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.4615858793258667,23537170,1,Miyobo,2005,2005,pfmdr1 86Y,181,118,152,Mendes C,2013,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Data also stratified by dry/wet season. Addit,23537170,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Amodiaquine,pfmdr1 86Y,84,NA,46.15858793258667,65.19337016574586
Equatorial Guinea,Central Africa,2.04,9.78,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.48547857999801636,23537170,2,Ngonamanga,2005,2005,pfmdr1 86Y,113,63,96,Mendes C,2013,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Data also stratified by dry/wet season. Addit,23537170,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Amodiaquine,pfmdr1 86Y,85,NA,48.54785799980163,55.75221238938053
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.16366708278656006,806,3,NA,2004,2005,pfmdr1 86Y,262,220,220,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, González V, García L, Rodríguez-Galet A, Díaz-Regañón R, Galán R, Cerrada-Gálvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,NA,34906159,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20 years (1999 to 2019).,Amodiaquine,pfmdr1 86Y,96,NA,16.366708278656006,83.96946564885496
Ethiopia,East Africa,6.41,38.31,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.15085846185684204,16817953,0,Dilla,2004,2004,pfmdr1 86Y,69,45,56,Schunk M,2006,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1524791&tool=pmcentrez&rendertype=abstract,NA,16817953,High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.,Amodiaquine,pfmdr1 86Y,81,NA,15.085846185684204,65.21739130434783
Gabon,Central Africa,-0.7,10.24,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.23836833238601685,17096149,2,Lambaréné,2002,2002,pfmdr1 86Y,60,2,4,Mayengue PI,2007,http://www.ncbi.nlm.nih.gov/pubmed/17096149,Stratification severe vs uncomplicated malari,17096149,No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria.,Amodiaquine,pfmdr1 86Y,92,NA,23.836833238601685,3.3333333333333335
Gabon,Central Africa,-1.63,13.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.11764557659626007,21251998,1,Franceville,2004,2004,pfmdr1 86Y,96,72,81,Lekana-Douki JB,2011,http://www.ncbi.nlm.nih.gov/pubmed/21251998,NA,21251998,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",Amodiaquine,pfmdr1 86Y,84,NA,11.764557659626009,75
Gambia,West Africa,13.57,-15.61,NA,NA,NA,2000,NA,15388456,0,Farafenni,2000,2000,pfmdr1 86Y,91,45,45,Hallett RL,2004,http://www.ncbi.nlm.nih.gov/pubmed/?term=15388456,Publication only contains  data from gametocy,15388456,Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.,Amodiaquine,pfmdr1 86Y,49,NA,NA,49.45054945054945
Gambia,West Africa,13.57,-15.61,NA,NA,NA,2000,NA,18008244,3,Farafenni Hospital,2000,2000,pfmdr1 86Y,90,45,45,Ord R,2007,http://www.ncbi.nlm.nih.gov/pubmed/18008244,Intraseasonal changes studied.,18008244,Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites.,Amodiaquine,pfmdr1 86Y,62,I,NA,50
Gambia,West Africa,13.57,-15.61,NA,NA,NA,2001,NA,18008244,4,Farafenni Hospital,2001,2001,pfmdr1 86Y,89,55,55,Ord R,2007,http://www.ncbi.nlm.nih.gov/pubmed/18008244,Intraseasonal changes studied.,18008244,Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites.,Amodiaquine,pfmdr1 86Y,62,I,NA,61.79775280898876
Gambia,West Africa,13.57,-15.61,NA,NA,NA,2002,NA,16206082,0,Farafenni,2002,2002,pfmdr1 86Y,185,84,84,Meerman L,2005,http://www.ncbi.nlm.nih.gov/pubmed/16206082,Mixed infections rare. Severe malaria vs. Con,16206082,Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children.,Amodiaquine,pfmdr1 86Y,45,NA,NA,45.40540540540541
Gambia,West Africa,13.57,-15.61,NA,NA,NA,2002,NA,18008244,5,Farafenni Hospital,2002,2002,pfmdr1 86Y,83,42,42,Ord R,2007,http://www.ncbi.nlm.nih.gov/pubmed/18008244,Intraseasonal changes studied.,18008244,Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites.,Amodiaquine,pfmdr1 86Y,62,I,NA,50.602409638554214
Ghana,West Africa,9.41,-0.85,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2000,0.4866935908794403,16117966,0,Tamale,2000,2000,pfmdr1 86Y,276,132,132,Ehrhardt S,2003,http://www.ncbi.nlm.nih.gov/pubmed/?term=16117966,Displayed prevalence refers to parasite genot,16117966,Chloroquine blood concentrations and molecular markers of chloroquine-resistant Plasmodium falciparum in febrile children in northern Ghana.,Amodiaquine,pfmdr1 86Y,48,I,48.66935908794403,47.82608695652174
Ghana,West Africa,7.15,0.46,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.1646893471479416,17158810,1,Hohoe,2004,2004,pfmdr1 86Y,130,78,101,Duah NO,2007,http://www.ncbi.nlm.nih.gov/pubmed/17158810,NA,17158810,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",Amodiaquine,pfmdr1 86Y,78,NA,16.46893471479416,60
Ghana,West Africa,10.9,-1.1,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.45202863216400146,17158810,2,Navrongo,2004,2004,pfmdr1 86Y,105,56,61,Duah NO,2007,http://www.ncbi.nlm.nih.gov/pubmed/17158810,NA,17158810,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",Amodiaquine,pfmdr1 86Y,58,NA,45.20286321640015,53.333333333333336
Ghana,West Africa,9.43,-0.02,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.5786017179489136,17158810,5,Yendi,2004,2004,pfmdr1 86Y,67,20,28,Duah NO,2007,http://www.ncbi.nlm.nih.gov/pubmed/17158810,NA,17158810,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",Amodiaquine,pfmdr1 86Y,42,NA,57.86017179489136,29.850746268656714
Ghana,West Africa,7.33,-2.33,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.40791749954223633,17158810,4,Sunyani,2004,2004,pfmdr1 86Y,62,24,33,Duah NO,2007,http://www.ncbi.nlm.nih.gov/pubmed/17158810,NA,17158810,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",Amodiaquine,pfmdr1 86Y,53,NA,40.79174995422363,38.70967741935484
Ghana,West Africa,7.33,-2.33,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.40791749954223633,17158810,4,Sunyani,2004,2004,pfmdr1 86Y,62,24,33,Duah NO,2007,http://www.ncbi.nlm.nih.gov/pubmed/17158810,NA,17158810,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",Amodiaquine,pfmdr1 86Y,53,NA,40.79174995422363,38.70967741935484
Ghana,West Africa,6.45,-1.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.20624059438705444,24172030,1,"Bekwai, Begoro,Hohoe, Sunyani, Tarkwa, Navrongo, Wa, Yendi, Cape-Coast",2003,2004,pfmdr1 86Y,324,194,194,Duah NO,2013,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,NA,24172030,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,Amodiaquine,pfmdr1 86Y,60,I,20.624059438705444,59.876543209876544
Guinea-Bissau,West Africa,11.88,-15.62,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.10648832470178604,25421474,0,Bissau,2003,2003,pfmdr1 86Y,317,149,149,Jovel IT,2015,http://www.ncbi.nlm.nih.gov/pubmed/25421474,NA,25421474,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",Amodiaquine,pfmdr1 86Y,48,I,10.648832470178604,47.003154574132495
Guinea-Bissau,West Africa,11.85,-15.6,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.07111933082342148,19718439,1,Bissau,2003,2003,pfmdr1 86Y,319,150,150,Ursing J,2009,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Stratification by month and parasitemia in th,19718439,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Amodiaquine,pfmdr1 86Y,47,I,7.111933082342148,47.02194357366771
Guinea-Bissau,West Africa,11.88,-15.62,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.056776776909828186,25421474,1,Bissau,2004,2004,pfmdr1 86Y,155,66,66,Jovel IT,2015,http://www.ncbi.nlm.nih.gov/pubmed/25421474,NA,25421474,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",Amodiaquine,pfmdr1 86Y,48,I,5.677677690982819,42.58064516129032
Guinea-Bissau,West Africa,11.87,-15.6,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.037504684180021286,17488902,0,NA,2001,2004,pfmdr1 86Y,477,227,227,Ursing J,2007,http://www.ncbi.nlm.nih.gov/pubmed/17488902,"Clinical CQ, high dose CQ and AQ data and pos",17488902,Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau.,Amodiaquine,pfmdr1 86Y,48,I,3.7504684180021286,47.58909853249476
Guinea-Bissau,West Africa,11.87,-15.6,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.037504684180021286,19718439,2,Bissau,2004,2004,pfmdr1 86Y,157,66,66,Ursing J,2009,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Stratification by month and parasitemia in th,19718439,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Amodiaquine,pfmdr1 86Y,43,I,3.7504684180021286,42.038216560509554
Guinea-Bissau,West Africa,11.96,-15.54,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.08010789006948471,17467343,4,"Nhacra, Placc",2004,2004,pfmdr1 86Y,74,15,37,Ursing J,2007,http://www.ncbi.nlm.nih.gov/pubmed/17467343,In vitro data available,17467343,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,Amodiaquine,pfmdr1 86Y,70,NA,8.010789006948471,20.27027027027027
Guinea-Bissau,West Africa,11.88,-15.62,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.03757215291261673,25421474,2,Bissau,2005,2005,pfmdr1 86Y,170,61,61,Jovel IT,2015,http://www.ncbi.nlm.nih.gov/pubmed/25421474,NA,25421474,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",Amodiaquine,pfmdr1 86Y,48,I,3.757215291261673,35.88235294117647
Guinea-Bissau,West Africa,11.87,-15.6,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.02451827935874462,19718439,3,Bissau,2005,2005,pfmdr1 86Y,168,62,62,Ursing J,2009,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Stratification by month and parasitemia in th,19718439,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Amodiaquine,pfmdr1 86Y,43,I,2.451827935874462,36.904761904761905
India,Asia,21.58,83.53,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.0001604546414455399,22236376,1,Orissa,2003,2003,pfmdr1 86Y,54,26,26,Mallick PK,2012,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3283508&tool=pmcentrez&rendertype=abstract,Post-treatment (CQ) genotypes available,22236376,"Mutant pfcrt ""SVMNT"" haplotype and wild type pfmdr1 ""N86"" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.",Amodiaquine,pfmdr1 86Y,48,NA,0.01604546414455399,48.148148148148145
India,Asia,28.57,77.55,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.0003267121792305261,16586369,1,Uttar Pradesh,2000,2004,pfmdr1 86Y,61,7,7,Mittra P,2006,http://www.ncbi.nlm.nih.gov/pubmed/16586369,NA,16586369,Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India.,Amodiaquine,pfmdr1 86Y,11,NA,0.03267121792305261,11.475409836065571
Indonesia,SEA,-7.74,110.03,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2000,2.732807047323149e-7,14740877,0,Purworejo,2000,2000,pfmdr1 86Y,111,103,105,SYAFRUDDIN D,2003,http://www.ncbi.nlm.nih.gov/pubmed/14740877,NA,14740877,Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Purworejo district,Amodiaquine,pfmdr1 86Y,95,NA,2.732807047323149e-5,92.7927927927928
Indonesia,SEA,1.13,97.52,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,9.667624339959602e-11,17760967,0,Nias archipelago,2005,2005,pfmdr1 86Y,77,22,22,Syafruddin D,2007,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2014775&tool=pmcentrez&rendertype=abstract,NA,17760967,"Malaria prevalence in Nias District, North Sumatra Province, Indonesia.",Amodiaquine,pfmdr1 86Y,40,NA,9.667624339959602e-9,28.57142857142857
Iran,Asia,25.29,60.64,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0,16490179,0,Chabahar City,2001,2002,pfmdr1 86Y,88,63,63,Ursing J,2006,http://www.ncbi.nlm.nih.gov/pubmed/16490179,NA,16490179,Quinoline resistance associated polymorphisms in the pfcrt,Amodiaquine,pfmdr1 86Y,72,NA,0,71.5909090909091
Iran,Asia,25.29,60.64,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0,17999755,1,Chabahar,2003,2005,pfmdr1 86Y,152,63,64,Zakeri S,2007,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2214731&tool=pmcentrez&rendertype=abstract,NA,17999755,Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.,Amodiaquine,pfmdr1 86Y,42,NA,0,41.44736842105263
Iran,Asia,25.29,60.64,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0,18385361,0,Chabahar district,2002,2005,pfmdr1 86Y,175,64,64,Zakeri S,2008,http://www.ncbi.nlm.nih.gov/pubmed/18385361,Clinical CQ data available.,18385361,Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum.,Amodiaquine,pfmdr1 86Y,37,NA,0,36.57142857142857
Iran,Asia,26.63,61.26,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0,17999755,2,Sarbaz,2003,2005,pfmdr1 86Y,54,15,16,Zakeri S,2007,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2214731&tool=pmcentrez&rendertype=abstract,NA,17999755,Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.,Amodiaquine,pfmdr1 86Y,30,NA,0,27.77777777777778
Kenya,East Africa,-0.06,34.24,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.6711243987083435,16271310,0,Siaya district,2003,2003,pfmdr1 86Y,91,58,58,Holmgren G,2006,http://www.ncbi.nlm.nih.gov/pubmed/16271310,Clinical AQ data and post-treatment genotypes,16271310,Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y.,Amodiaquine,pfmdr1 86Y,64,I,67.11243987083435,63.73626373626373
Kenya,East Africa,-0.04,34.55,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.298454612493515,18671871,3,Kombewa,2005,2005,pfmdr1 86Y,200,69,135,Zhong D,2008,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Stratification asymptomatic vs. Symptomatic i,18671871,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Amodiaquine,pfmdr1 86Y,68,NA,29.8454612493515,34.5
Kenya,East Africa,-0.04,34.55,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.298454612493515,614,2,Kombewa,2005,2005,pfmdr1 86Y,73,15,46,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,asymptomatic,29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",Amodiaquine,pfmdr1 86Y,67,NA,29.8454612493515,20.54794520547945
Kenya,East Africa,0.28,34.75,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.19982437789440155,18671871,2,Kakamega,2005,2005,pfmdr1 86Y,200,67,149,Zhong D,2008,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Stratification asymptomatic vs. symptomatic i,18671871,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Amodiaquine,pfmdr1 86Y,75,NA,19.982437789440155,33.5
Kenya,East Africa,0.28,34.75,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.19982437789440155,614,6,Kakamega,2005,2005,pfmdr1 86Y,108,45,79,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,asymptomatic,29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",Amodiaquine,pfmdr1 86Y,79,NA,19.982437789440155,41.66666666666667
Kenya,East Africa,-0.09,34.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.24521037936210632,21106088,0,Kisumu,2003,2005,pfmdr1 86Y,243,184,184,Spalding MD,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3001743&tool=pmcentrez&rendertype=abstract,Results from an additional study was presente,21106088,"Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.",Amodiaquine,pfmdr1 86Y,76,I,24.521037936210632,75.7201646090535
Kenya,East Africa,-0.09,34.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.24521037936210632,21106088,0,Kisumu,2003,2005,pfmdr1 86Y,243,184,184,Spalding MD,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3001743&tool=pmcentrez&rendertype=abstract,Results from an additional study was presente,21106088,"Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.",Amodiaquine,pfmdr1 86Y,76,I,24.521037936210632,75.7201646090535
Kenya,East Africa,-0.68,34.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.07876604050397873,18671871,1,Kisii,2005,2005,pfmdr1 86Y,200,33,91,Zhong D,2008,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Stratification asymptomatic vs. symptomatic i,18671871,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Amodiaquine,pfmdr1 86Y,46,NA,7.876604050397873,16.5
Lao People's Democratic Republic,SEA,14.94,107.1,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.03646837919950485,12950663,0,Attapeu Province,2001,2001,pfmdr1 86Y,65,9,9,Berens N,2003,http://www.ncbi.nlm.nih.gov/pubmed/12950663,"Clinical CQ, SP and CQ+SP data.",12950663,Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR.,Amodiaquine,pfmdr1 86Y,14,NA,3.646837919950485,13.846153846153848
Madagascar,East Africa,-21.82,47.33,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.06291463226079941,17556614,1,Saharevo,2004,2004,pfmdr1 86Y,64,48,48,Rason MA,2007,http://www.ncbi.nlm.nih.gov/pubmed/17556614,In vitro data available.,17556614,Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.,Amodiaquine,pfmdr1 86Y,75,NA,6.291463226079941,75
Malawi,Southern Africa,-15.79,35.01,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.1825326681137085,17556619,0,Blantyre,2003,2004,pfmdr1 86Y,56,1,1,Nkhoma S,2007,http://www.ncbi.nlm.nih.gov/pubmed/17556619,In vitro data available.,17556619,In vitro antimalarial susceptibility profile and prcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi.,Amodiaquine,pfmdr1 86Y,2,NA,18.25326681137085,1.7857142857142856
Malawi,Southern Africa,-15.79,35.01,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.1296924501657486,18270569,0,Blantyre,2003,2005,pfmdr1 86Y,244,25,25,Bell DJ,2008,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2229666&tool=pmcentrez&rendertype=abstract,Clinical SP and SP combinations data and post,18270569,"Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.",Amodiaquine,pfmdr1 86Y,10,NA,12.96924501657486,10.245901639344265
Mali,West Africa,12.61,-8.14,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.4452325701713562,19245687,1,Bamako,2002,2003,pfmdr1 86Y,136,67,67,"Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK",2009,http://www.ncbi.nlm.nih.gov/pubmed/?term=19245687,NA,19245687,"Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.",Amodiaquine,pfmdr1 86Y,49,NA,44.52325701713562,49.26470588235294
Mali,West Africa,10.78,-6.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.4166281521320343,18337343,0,Bougoula-Hameau,2002,2004,pfmdr1 86Y,170,98,98,Djimdé AA,2008,http://www.ncbi.nlm.nih.gov/pubmed/18337343,"Clinical ASAQ, AS+SP data and post-treatment",18337343,"Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.",Amodiaquine,pfmdr1 86Y,58,I,41.66281521320343,57.647058823529406
Mali,West Africa,12.61,-8.14,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.42161825299263,19245687,2,Bamako,2003,2004,pfmdr1 86Y,169,60,60,"Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK",2009,http://www.ncbi.nlm.nih.gov/pubmed/?term=19245687,NA,19245687,"Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.",Amodiaquine,pfmdr1 86Y,49,NA,42.161825299263,35.50295857988166
Mozambique,Southern Africa,-25.97,32.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.12005121260881424,25098280,0,Maputo,2003,2005,pfmdr1 86Y,133,26,55,Lobo E,2014,http://www.ncbi.nlm.nih.gov/pubmed/25098280,NA,25098280,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,Amodiaquine,pfmdr1 86Y,86,NA,12.005121260881424,19.548872180451127
Nigeria,West Africa,7.4,3.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.31675952672958374,22302850,1,Ibadan,2004,2004,pfmdr1 86Y,70,32,32,Gbotosho GO,2012,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3269269&tool=pmcentrez&rendertype=abstract,Not clear how mixed infections were accounted,22302850,Different patterns of pfcrt and pfmdr1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: the potential role of antimalarial drug selection pressure.,Amodiaquine,pfmdr1 86Y,46,NA,31.675952672958378,45.714285714285715
Nigeria,West Africa,7.4,3.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.31675952672958374,16874478,0,Ibadan,2002,2004,pfmdr1 86Y,111,39,76,Happi CT,2006,http://www.ncbi.nlm.nih.gov/pubmed/16874478,Clinical CQ data and post-treatment genotype,16874478,Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria.,Amodiaquine,pfmdr1 86Y,68,NA,31.675952672958378,35.13513513513514
Nigeria,West Africa,7.4,3.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.31027185916900635,16837724,0,Ibadan,2005,2005,pfmdr1 86Y,101,28,57,Happi CT,2006,http://www.ncbi.nlm.nih.gov/pubmed/16837724,Clinical AQ data available.,16837724,Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.,Amodiaquine,pfmdr1 86Y,56,NA,31.027185916900635,27.72277227722773
Nigeria,West Africa,7.4,3.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.31027185916900635,19953193,0,Ibadan,2005,2005,pfmdr1 86Y,81,27,55,Folarin OA,2008,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785046/pdf/nihms75070.pdf,In vitro data available.,19953193,"Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.",Amodiaquine,pfmdr1 86Y,68,NA,31.027185916900635,33.33333333333333
Nigeria,West Africa,7.77,4.56,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.3271143138408661,17428334,0,Osogbo,2004,2005,pfmdr1 86Y,116,34,42,Ojurongbe O,2007,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855061&tool=pmcentrez&rendertype=abstract,Clinical CQ data and post-treatment genotypes,17428334,"Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.",Amodiaquine,pfmdr1 86Y,36,NA,32.71143138408661,29.310344827586203
Papua New Guinea,Oceania,-4.46,143.22,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.014887833036482334,20053293,4,"South Wosera_x000d_
South Wosera",2003,2003,pfmdr1 86Y,106,105,106,Marfurt J,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2820042&tool=pmcentrez&rendertype=abstract,NA,20053293,Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.,Amodiaquine,pfmdr1 86Y,100,NA,1.4887833036482334,99.05660377358492
Papua New Guinea,Oceania,-3.58,143.65,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.00002960802157758735,16620743,0,Wewak,2002,2003,pfmdr1 86Y,113,96,97,Mita T,2006,http://www.ncbi.nlm.nih.gov/pubmed/16620743,In vitro data available.,16620743,Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea.,Amodiaquine,pfmdr1 86Y,86,NA,0.00296080215775873,84.95575221238938
Papua New Guinea,Oceania,-4.46,144.82,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.057814985513687134,20053293,1,Karimui,2003,2003,pfmdr1 86Y,93,93,93,Marfurt J,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2820042&tool=pmcentrez&rendertype=abstract,"Clinical data of AQ, CQ+SP",20053293,Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.,Amodiaquine,pfmdr1 86Y,100,NA,5.781498551368713,100
Papua New Guinea,Oceania,-4.98,145.78,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.000167701713507995,20053293,6,North Coast Madang,2004,2004,pfmdr1 86Y,119,76,88,Marfurt J,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2820042&tool=pmcentrez&rendertype=abstract,NA,20053293,Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.,Amodiaquine,pfmdr1 86Y,74,NA,0.0167701713507995,63.86554621848739
Papua New Guinea,Oceania,-4.46,143.22,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.01453348807990551,20053293,5,South Wosera,2004,2004,pfmdr1 86Y,95,86,90,Marfurt J,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2820042&tool=pmcentrez&rendertype=abstract,NA,20053293,Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.,Amodiaquine,pfmdr1 86Y,100,NA,1.453348807990551,90.52631578947368
Papua New Guinea,Oceania,-4.46,144.82,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.057948313653469086,20053293,2,Karimui,2004,2004,pfmdr1 86Y,70,70,70,Marfurt J,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2820042&tool=pmcentrez&rendertype=abstract,NA,20053293,Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.,Amodiaquine,pfmdr1 86Y,100,NA,5.794831365346909,100
Papua New Guinea,Oceania,-4.46,144.82,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.057948313653469086,18423045,0,"Karimui, South Wosera",2003,2004,pfmdr1 86Y,174,150,159,Marfurt J,2008,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2377269&tool=pmcentrez&rendertype=abstract,Clinical AQ+SP data and post-treatment genoty,18423045,The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.,Amodiaquine,pfmdr1 86Y,91,NA,5.794831365346909,86.20689655172413
Papua New Guinea,Oceania,-4.46,144.82,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.05072769150137901,20053293,3,Karimui,2005,2005,pfmdr1 86Y,128,128,128,Marfurt J,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2820042&tool=pmcentrez&rendertype=abstract,NA,20053293,Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.,Amodiaquine,pfmdr1 86Y,100,NA,5.072769150137901,100
Sao Tome and Principe,Central Africa,0.33,6.73,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.6000000238418579,17313506,0,Sao Tomé,2004,2004,pfmdr1 86Y,70,15,25,Ferreira ID,2007,http://www.ncbi.nlm.nih.gov/pubmed/17313506,"In vitro data on AQ, ARM and AS available.",17313506,"In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.",Amodiaquine,pfmdr1 86Y,36,NA,60.00000238418579,21.428571428571427
Senegal,West Africa,14.75,-17.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.026827603578567505,22706959,2,Pikine,2001,2001,pfmdr1 86Y,53,13,13,Ly O,2012,http://www.ncbi.nlm.nih.gov/pubmed/22706959,In vitro data,22706959,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",Amodiaquine,pfmdr1 86Y,41,NA,2.6827603578567505,24.528301886792452
Senegal,West Africa,14.75,-17.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.0268393624573946,22706959,3,Pikine,2002,2002,pfmdr1 86Y,79,30,30,Ly O,2012,http://www.ncbi.nlm.nih.gov/pubmed/22706959,NA,22706959,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",Amodiaquine,pfmdr1 86Y,41,NA,2.68393624573946,37.9746835443038
Senegal,West Africa,14.75,-17.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.041625577956438065,22706959,4,Pikine,2003,2003,pfmdr1 86Y,70,29,29,Ly O,2012,http://www.ncbi.nlm.nih.gov/pubmed/22706959,NA,22706959,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",Amodiaquine,pfmdr1 86Y,41,NA,4.1625577956438065,41.42857142857143
Senegal,West Africa,14.75,-17.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.030653785914182663,22706959,5,Pikine,2004,2004,pfmdr1 86Y,79,21,21,Ly O,2012,http://www.ncbi.nlm.nih.gov/pubmed/22706959,NA,22706959,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",Amodiaquine,pfmdr1 86Y,41,NA,3.0653785914182663,26.582278481012654
Senegal,West Africa,14.75,-17.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.027869854122400284,22706959,6,Pikine,2005,2005,pfmdr1 86Y,98,19,19,Ly O,2012,http://www.ncbi.nlm.nih.gov/pubmed/22706959,NA,22706959,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",Amodiaquine,pfmdr1 86Y,41,NA,2.7869854122400284,19.387755102040817
Solomon Islands,Oceania,-8,159,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.38042140007019043,20925934,0,Tetere,2004,2005,pfmdr1 86Y,62,62,62,Ballif M,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2959069&tool=pmcentrez&rendertype=abstract,Asymptomatic,20925934,Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.,Amodiaquine,pfmdr1 86Y,100,NA,38.04214000701904,100
South Sudan,East Africa,4.84,31.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.36875471472740173,13677373,0,NA,2001,2001,pfmdr1 86Y,84,16,16,Ochong EO,2003,http://www.ncbi.nlm.nih.gov/pubmed/13677373,Clinical CQ and AQ data available.,13677373,Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan.,Amodiaquine,pfmdr1 86Y,19,NA,36.87547147274017,19.047619047619047
Sudan,East Africa,15.62,32.64,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.009619023650884628,16171768,2,Haj Yousif,2001,2001,pfmdr1 86Y,78,67,72,Tagelsir N,2006,http://www.ncbi.nlm.nih.gov/pubmed/16171768,Clinical CQ data available.,16171768,High frequency of Plasmodium falciparum PfCRT K76T and PfpghN86Y in patients clearing infection after chloroquine treatment in the Sudan.,Amodiaquine,pfmdr1 86Y,92,NA,0.9619023650884628,85.8974358974359
Sudan,East Africa,14.03,35.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.08362725377082825,16171768,1,Gadaref,2001,2001,pfmdr1 86Y,81,58,75,Tagelsir N,2006,http://www.ncbi.nlm.nih.gov/pubmed/16171768,Clinical CQ data available.,16171768,High frequency of Plasmodium falciparum PfCRT K76T and PfpghN86Y in patients clearing infection after chloroquine treatment in the Sudan.,Amodiaquine,pfmdr1 86Y,93,NA,8.362725377082825,71.60493827160494
Sudan,East Africa,14.04,35.39,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.08362725377082825,16336938,0,Gedarif Hospital,2000,2001,pfmdr1 86Y,99,71,76,Giha HA,2006,http://www.ncbi.nlm.nih.gov/pubmed/16336938,Stratification of genotypes in mild vs. Sever,16336938,Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission.,Amodiaquine,pfmdr1 86Y,77,NA,8.362725377082825,71.71717171717171
Sudan,East Africa,9.54,30.41,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.181036576628685,14641841,0,Akuem,2002,2002,pfmdr1 86Y,95,28,34,Anderson TJC,2003,http://www.ncbi.nlm.nih.gov/pubmed/14641841,NA,14641841,Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province,Amodiaquine,pfmdr1 86Y,36,NA,18.1036576628685,29.47368421052631
Sudan,East Africa,11.75,30.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.0555371418595314,20212335,0,Nuba Montains,2003,2004,pfmdr1 86Y,160,143,147,Yusuf RU,2010,http://www.jidc.org/index.php/journal/article/view/20212335,"Clinical data AS+SP, AQ+SP",20212335,The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.,Amodiaquine,pfmdr1 86Y,92,NA,5.55371418595314,89.375
Tanzania,East Africa,-5.16,38.44,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.3398488759994507,22144430,1,Korogwe,2003,2003,pfmdr1 86Y,148,104,118,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,CROSS-SECTIONAL STUDY,22144430,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,Amodiaquine,pfmdr1 86Y,92,NA,33.98488759994507,70.27027027027027
Tanzania,East Africa,-6.17,39.2,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.20063228905200958,17467344,2,NA,2002,2003,pfmdr1 86Y,224,168,168,Holmgren G,2007,http://www.ncbi.nlm.nih.gov/pubmed/17467344,Clinical ASAQ data and post-treatment genotyp,17467344,Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.,Amodiaquine,pfmdr1 86Y,77,I,20.06322890520096,75
Tanzania,East Africa,-6.17,39.2,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.20063228905200958,16163624,0,"Micheweni, Kivunge",2002,2003,pfmdr1 86Y,443,335,335,Mårtensson A,2005,http://www.ncbi.nlm.nih.gov/pubmed/16163624,Clinical AS+AQ and AL data and post-treatment,16163624,Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar,Amodiaquine,pfmdr1 86Y,76,I,20.06322890520096,75.62076749435666
Tanzania,East Africa,-6.17,39.2,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.20063228905200958,15717281,0,"Micheweni, Kivunge",2002,2003,pfmdr1 86Y,189,140,160,Sisowath C,2005,http://www.ncbi.nlm.nih.gov/pubmed/15717281,Post-treatment (AL) genotype data available.,15717281,In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).,Amodiaquine,pfmdr1 86Y,85,NA,20.06322890520096,74.07407407407408
Tanzania,East Africa,-5.18,38.79,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.5323069095611572,17194834,0,Muheza,2002,2004,pfmdr1 86Y,190,158,177,Humphreys GS,2007,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr",17194834,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,Amodiaquine,pfmdr1 86Y,93,NA,53.23069095611572,83.15789473684211
Tanzania,East Africa,-5.16,38.44,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.29021531343460083,22144430,2,Korogwe,2004,2004,pfmdr1 86Y,293,205,264,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,CROSS-SECTIONAL STUDY,22144430,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,Amodiaquine,pfmdr1 86Y,92,NA,29.021531343460083,69.96587030716724
Tanzania,East Africa,-6.4,38.67,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.48223215341567993,19210165,0,Fukayosi,2004,2004,pfmdr1 86Y,102,45,45,Sisowath C,2009,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Clinical data AL. Post-treatment genotypes av,19210165,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Amodiaquine,pfmdr1 86Y,44,NA,48.22321534156799,44.11764705882353
Tanzania,East Africa,-6.17,39.2,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.049419812858104706,17467344,3,NA,2005,2005,pfmdr1 86Y,193,149,149,Holmgren G,2007,http://www.ncbi.nlm.nih.gov/pubmed/17467344,Clinical ASAQ data and post-treatment genotyp,17467344,Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.,Amodiaquine,pfmdr1 86Y,77,I,4.941981285810471,77.2020725388601
Tanzania,East Africa,-6.17,39.2,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.049419812858104706,25917493,1,"Micheweni, North A",2005,2005,pfmdr1 86Y,119,77,91,Morris U,2015,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Asymptomatic,25917493,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Amodiaquine,pfmdr1 86Y,89,NA,4.941981285810471,64.70588235294117
Tanzania,East Africa,-8.9,33.45,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.032487593591213226,17224049,0,"Mbeya, Matema",2004,2005,pfmdr1 86Y,85,38,44,Schönfeld M,2007,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1781949&tool=pmcentrez&rendertype=abstract,NA,17224049,Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.,Amodiaquine,pfmdr1 86Y,52,NA,3.248759359121322,44.70588235294118
Thailand,SEA,19.71,98.63,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.000326829613186419,16652314,0,Northwestern border of Thailand,1995,2002,pfmdr1 86Y,78,4,4,Price RN,2006,http://www.ncbi.nlm.nih.gov/pubmed/16652314,"Clinical AL data, lumefantrine concentration",16652314,Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.,Amodiaquine,pfmdr1 86Y,5,NA,0.0326829613186419,5.128205128205128
Thailand,SEA,16.88,99.13,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.00009915282862493768,16045457,1,"Tak, Chanthaburi",2001,2003,pfmdr1 86Y,100,2,2,Congpuong K,2005,http://www.ncbi.nlm.nih.gov/pubmed/16045457,In vitro data available.,16045457,Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand.,Amodiaquine,pfmdr1 86Y,2,NA,0.00991528286249376,2
Thailand,SEA,14.02,99.53,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0,21320353,0,"Kanchanaburi, Tak, Ratchaburi, Ranong and Chantaburi Provinces",1998,2003,pfmdr1 86Y,95,5,5,Chaijaroenkul W,2011,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3055224&tool=pmcentrez&rendertype=abstract,New pfcrt SNPs and deletions identified in on,21320353,Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparum.,Amodiaquine,pfmdr1 86Y,5,NA,0,5.263157894736842
Thailand,SEA,14.48,100.85,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.000012384119145281147,17124182,0,Mawker-Thai,2000,2003,pfmdr1 86Y,326,13,13,Nair S,2007,http://www.ncbi.nlm.nih.gov/pubmed/17124182,Pfmdr1 flanking microsatellites. Mixed infect,17124182,Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites.,Amodiaquine,pfmdr1 86Y,4,NA,0.00123841191452811,3.9877300613496938
Thailand,SEA,9.95,98.61,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.0011058334494009614,16045457,3,"Ranong, Chiengmai",2001,2003,pfmdr1 86Y,118,3,10,Congpuong K,2005,http://www.ncbi.nlm.nih.gov/pubmed/16045457,In vitro data available.,16045457,Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand.,Amodiaquine,pfmdr1 86Y,8,NA,0.11058334494009614,2.5423728813559325
Thailand,SEA,13.73,100.52,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0,18950599,0,Thai borders,2002,2004,pfmdr1 86Y,110,22,27,Rungsihirunrat K,2009,http://www.ncbi.nlm.nih.gov/pubmed/18950599,In vitro data.,18950599,Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand.,Amodiaquine,pfmdr1 86Y,25,NA,0,20
Timor-Leste,SEA,-8.55,125.57,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.037585049867630005,19358729,2,"Dili, Suai, Liquiça, Same, Viqueque, Lospalos",2004,2005,pfmdr1 86Y,66,37,48,de Almeida A,2009,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2672086&tool=pmcentrez&rendertype=abstract,NA,19358729,Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor.,Amodiaquine,pfmdr1 86Y,76,NA,3.758504986763001,56.060606060606055
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.9998051524162292,16641472,0,Tororo,2003,2003,pfmdr1 86Y,201,125,185,Dokomajilar C,2006,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472234/,Clinical AL data and post-treatment genotypes,16641472,Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic.,Amodiaquine,pfmdr1 86Y,92,NA,99.98051524162292,62.189054726368155
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.9998051524162292,24799371,0,Tororo,2003,2003,pfmdr1 86Y,192,36,172,Mbogo GW,2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Previously published genotype data in the art,24799371,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Amodiaquine,pfmdr1 86Y,90,NA,99.98051524162292,18.75
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.8842926621437073,17562798,0,Tororo,2004,2004,pfmdr1 86Y,201,182,182,Nsobya SL,2007,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1932488&tool=pmcentrez&rendertype=abstract,Clinical ASAQ data and post-treatment genotyp,17562798,Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.,Amodiaquine,pfmdr1 86Y,91,I,88.42926621437073,90.54726368159204
Viet nam,SEA,11.75,106.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.0006701205275021493,19889891,1,Binh Phuoc,2001,2001,pfmdr1 86Y,67,0,0,Isozumi R,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2812275&tool=pmcentrez&rendertype=abstract,Mixed infections excluded in haplotypes,19889891,Longitudinal survey of Plasmodium falciparum infection in Vietnam: characteristics of antimalarial resistance and their associated factors.,Amodiaquine,pfmdr1 86Y,0,NA,0.06701205275021493,0
Viet nam,SEA,11.75,106.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.0012224687961861491,19889891,1,Binh Phuoc,2001,2001,pfmdr1 86Y,67,0,0,Isozumi R,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2812275&tool=pmcentrez&rendertype=abstract,Mixed infections excluded in haplotypes,19889891,Longitudinal survey of Plasmodium falciparum infection in Vietnam: characteristics of antimalarial resistance and their associated factors.,Amodiaquine,pfmdr1 86Y,0,NA,0.12224687961861493,0
Viet nam,SEA,11.75,106.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.0003883063327521086,19889891,2,Binh Phuoc,2002,2002,pfmdr1 86Y,91,0,0,Isozumi R,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2812275&tool=pmcentrez&rendertype=abstract,NA,19889891,Longitudinal survey of Plasmodium falciparum infection in Vietnam: characteristics of antimalarial resistance and their associated factors.,Amodiaquine,pfmdr1 86Y,0,NA,0.03883063327521086,0
Viet nam,SEA,11.75,106.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.0007419979083351791,19889891,2,Binh Phuoc,2002,2002,pfmdr1 86Y,91,0,0,Isozumi R,2010,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2812275&tool=pmcentrez&rendertype=abstract,NA,19889891,Longitudinal survey of Plasmodium falciparum infection in Vietnam: characteristics of antimalarial resistance and their associated factors.,Amodiaquine,pfmdr1 86Y,0,NA,0.07419979083351791,0
